Effects of Blood Flow Restriction and Small-Sided Games on Soccer Passing and Dribbling Stability Under Fatigue (BFR-SSG)

March 23, 2026 updated by: Yue Dou, Beijing Sport University

Effects of Blood Flow Restriction Combined With Small-Sided Games on Passing and Dribbling Stability of Soccer Players Under Fatigue

This study aims to investigate whether applying blood flow restriction (BFR) during small-sided soccer games (SSG) can help soccer players maintain their passing and dribbling stability when they are fatigued. The study includes 40 young male soccer players. Participants will be randomly divided into two groups:

One group will wear pressurized BFR cuffs on their legs (80% of limb occlusion pressure) during a 4v4 training game.

The other group will act as a control, wearing the same cuffs but without any pressure (0% pressure) during the exact same training game.Both groups will complete a 6-week training program, practicing 3 times a week. Before and after the 6-week period, researchers will test the players' physical and technical skills (such as jumping, passing, and dribbling). Importantly, these tests will be conducted both before and immediately after a tiring 45-minute exercise routine to see which training method is more effective at preventing performance drops caused by fatigue.

Study Overview

Detailed Description

This study utilizes a randomized, single-blind, placebo-controlled parallel group design. A total of 40 young male soccer players with systematic training backgrounds will be recruited. Following baseline testing, participants will be randomly assigned to either the BFR-SSG group or the SSG control group.The intervention spans 6 weeks, featuring three standardized 90-minute training sessions per week. The core intervention consists of a 4v4 small-sided game module (4 sets of 4 minutes). During this module, the BFR-SSG group will wear pneumatic cuffs inflated to 80% of their individual Limb Occlusion Pressure (LOP), while the control group will wear uninflated cuffs (0% LOP).Pre- and post-intervention assessments will systematically evaluate physiological adaptations (blood lactate, creatine kinase) , neuromuscular function (Countermovement Jump) , and sport-specific technical stability (Loughborough Soccer Passing Test and a 20m change-of-direction dribbling test). To specifically assess performance under metabolic stress, the technical and neuromuscular tests will be conducted at baseline and immediately following a standardized 45-minute fatigue-inducing protocol (Modified LIST). The primary goal is to quantify the attenuation rate of passing and dribbling performance under fatigue and determine if BFR combined with SSG provides superior chronic adaptations compared to SSG alone

Study Type

Interventional

Enrollment (Actual)

40

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Beijing Municipality
      • Beijing, Beijing Municipality, China, 100084
        • China Football Institute, Beijing Sport University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Young male soccer players. Possess a systematic soccer specific training background and maintain a stable competitive state.

Cleared by the Physical Activity Readiness Questionnaire (PAR-Q), confirming that cardiovascular and metabolic systems can tolerate high-intensity physical testing and blood flow restriction interventions.

Exclusion Criteria:

  • Any recent history of neuromuscular or musculoskeletal system injuries. Current smoking habit. Consumption of any sports nutrition supplements or drinks that could significantly affect muscle performance or neural excitability (e.g., creatine, caffeine, beta-alanine) within 3 months prior to the start of the study and throughout the experimental period.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Basic Science
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Experimental: BFR-SSG Group
Participants are assigned to the blood flow restriction combined with small-sided games group. They wear compression cuffs inflated to 80% of their individualized Limb Occlusion Pressure (LOP) during the core small-sided games training.
The intervention lasts for 6 weeks, with 3 standardized 90-minute soccer training sessions per week. During the core 20-minute intervention module, participants play 4v4 small-sided games (4 sets of 4 minutes, with 2 minutes of rest between sets). Cuffs are inflated to 80% LOP during the exercise phase and fully deflated during the rest intervals.
Sham Comparator: Sham Comparator: SSG Control Group
Participants are assigned to the control group. They undergo the exact same small-sided games training while wearing identical cuffs that remain uninflated (0% LOP) to serve as a placebo.
Participants complete the identical 6-week standardized soccer training program (3 sessions per week) and the 4v4 small-sided games module. However, the cuffs worn by the participants remain at 0% LOP (uninflated) throughout the entire duration of the small-sided games.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Loughborough Soccer Passing Test (LSPT) Performance
Time Frame: Baseline (Week 0) and immediately post-intervention (Week 6). At both time points, the test is performed pre-fatigue and immediately post-fatigue.
The LSPT assesses passing skill and stability. The score is the total time (in seconds) required to complete 16 passes, plus penalty time added for passing errors. To evaluate passing stability under fatigue, the performance attenuation rate is calculated by comparing scores obtained before and immediately after a standardized 45-minute fatigue-inducing protocol (Modified LIST).
Baseline (Week 0) and immediately post-intervention (Week 6). At both time points, the test is performed pre-fatigue and immediately post-fatigue.
20m Change-of-Direction Dribbling Test Technical Deficit
Time Frame: Baseline (Week 0) and immediately post-intervention (Week 6). At both time points, measured pre-fatigue and immediately post-fatigue.
This test evaluates high-speed dribbling stability over a 20m slalom course. The primary metric is the "technical deficit," calculated by subtracting the time taken to complete the course without the ball (sprint) from the time taken with the ball (dribbling). This isolates technical stability from pure physical fatigue.
Baseline (Week 0) and immediately post-intervention (Week 6). At both time points, measured pre-fatigue and immediately post-fatigue.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Countermovement Jump (CMJ) Height
Time Frame: Baseline (Week 0) and immediately post-intervention (Week 6). Measured pre-fatigue and immediately post-fatigue at both time points.
Maximum vertical jump height (in centimeters) measured using a 3D force plate. It evaluates the attenuation of lower limb neuromuscular function and explosive power under metabolic stress.
Baseline (Week 0) and immediately post-intervention (Week 6). Measured pre-fatigue and immediately post-fatigue at both time points.
Yo-Yo Intermittent Recovery Test Level 1 (YYIRT-1) Distance
Time Frame: Baseline (Week 0) and post-intervention (Week 6). Tests are conducted on a separate day, at least 48 hours apart from the main testing day, to avoid residual fatigu
Total running distance (in meters) completed before exhaustion to assess chronic adaptations in soccer-specific intermittent endurance.
Baseline (Week 0) and post-intervention (Week 6). Tests are conducted on a separate day, at least 48 hours apart from the main testing day, to avoid residual fatigu
Creatine Kinase (CK) Concentration
Time Frame: Fasting baseline (Week 0), 24 hours after the first intervention session (Week 1), and 24 hours after the final intervention session (Week 6).
Absolute creatine kinase concentration (U/L) measured from fingertip capillary blood to evaluate skeletal muscle micro-damage and chronic adaptation
Fasting baseline (Week 0), 24 hours after the first intervention session (Week 1), and 24 hours after the final intervention session (Week 6).

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 20, 2026

Primary Completion (Actual)

March 10, 2026

Study Completion (Actual)

March 22, 2026

Study Registration Dates

First Submitted

March 22, 2026

First Submitted That Met QC Criteria

March 23, 2026

First Posted (Actual)

March 27, 2026

Study Record Updates

Last Update Posted (Actual)

March 27, 2026

Last Update Submitted That Met QC Criteria

March 23, 2026

Last Verified

March 1, 2026

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

Individual participant data will not be shared due to participant confidentiality and institutional data protectionpolicies.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Athletic Performance

Clinical Trials on Blood Flow Restriction + Small-Sided Games (BFR-SSG)

Subscribe